What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?

In the handful of similar cases that I have seen, I have worked with medical oncology to tease out a concurrent chemotherapy regimen. What we have often ended up doing is treating the head and neck cancer as normal (to 70 Gy) and the esophagus cancer to a relatively standard dose (usually to 50 Gy to keep 2 Gy fractions rather than the more standard 50.4 Gy) with concurrent carbo/taxol.

Carbo/taxol is our routine recommendation for cisplatin-ineligible patients, and while data may not be as robu...